0

Global Axial Spondyloarthritis Treatment Market 2018-2022

  • Published: Oct 2018
  • Pages: 105
  • SKU: IRTNTR23587
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global axial spondyloarthritis treatment market is predicted to register a CAGR of more than 7% by 2022 helped by the increase in the number of small molecules in the drug development pipeline. Wondering how to make the most of this booming axial spondyloarthritis treatment industry? Technavio’s extensive industry research report offers a detailed insight that will allow you to take full advantage of the opportunities available to you. This study provides an in-depth analysis of the market by considering the evolving demographics and consumer behavior in the global axial spondyloarthritis treatment market. It also examines the competitive landscape and some key vendors that include AbbVie, Amgen, and Johnson & Johnson.

Want to get a preview about how you can gain valuable insights from Technavio’s market research report? Check out the latest facts about the axial spondyloarthritis treatment industry

The global axial spondyloarthritis treatment market is expected to grow at a CAGR of more than 7% during the forecast period

Axial spondyloarthritis treatment industry growth is expected to accelerate over the next five years, driven by increase in the number of approved biosimilars that is widening the patient base. Biosimilars are the generic versions of biologics and are available at a lesser price than the original biologics. Considering the high cost of biologics, biosimilars appear as a cost-effective solution and the rise in the number of approved biosimilars will fuel the growth of the global axial spondyloarthritis market during the period of forecast. Technavio’s axial spondyloarthritis treatment industry analysis reveals promising markets around the world.

Want a bigger picture? Get a free sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

The Americas dominated the axial spondyloarthritis treatment market by region

The global axial spondyloarthritis treatment market was dominated by the Americas with a market share of almost 43%, followed by EMEA and APAC. However, APAC and EMEA will display a faster growth than the Americas over the period of forecast. Also, the Americas will drive around 41% of the growth for the global axial spondyloarthritis treatment market owing to presence of the US which is the largest pharmaceutical market in the world. However, APAC will register the fastest rate of growth over the next five years due to the large population and improving healthcare infrastructure in the region.

Get more value with Technavio’s subscription platform! Gain easy access to all Technavio’s reports, along with on-demand services. Start your 14-day FREE trial

AbbVie, Amgen, and Johnson & Johnson are among the leading axial spondyloarthritis treatment vendors

The global axial spondyloarthritis treatment market is forecasted to grow increasingly concentrated with the existence of a few international and regional vendors who offer axial spondyloarthritis treatment. Most of the established companies in the global axial spondyloarthritis treatment market are engaging in strategic alliances to strengthen their market position and extend their geographical reach. Many international and regional vendors are vying for their share of the axial spondyloarthritis market, and players must differentiate themselves to gain vital traction over their peers.

This report offers a complete analysis of several companies, including:

  • AbbVie
  • Amgen
  • Johnson & Johnson
  • Pfizer
  • UCB

Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements. Get in touch

 

Read More Read Less

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: PIPELINE LANDSCAPE

PART 08: MARKET SEGMENTATION BY CATEGORY

  • Segmentation by category
  • Comparison by category
  • Global ankylosing spondylitis treatment market – Market size and forecast 2017-2022
  • Global non-radiographic axial spondyloarthritis treatment market – Market size and forecast 2017-2022
  • Market opportunity by category

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas – Market size and forecast 2017-2022
  • EMEA – Market size and forecast 2017-2022
  • APAC – Market size and forecast 2017-2022
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AbbVie
  • Amgen
  • Johnson & Johnson
  • Pfizer
  • UCB

PART 16: APPENDIX

  • List of abbreviations

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>